In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...
Shares in Sarepta reversed some of their recent declines after the FDA added a warning label to its Duchenne muscular dystrophy (DMD) gene therapy, ending a protracted period of uncertainty for the ...
More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one backdated for November 24 for Daiichi Sankyo’s tenosynovial giant cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback